Home
Concord Drugs Ltd Share Price History
Concord Drugs Ltd
BSE : 21 Apr, 2025
31.40.7 (2.2%)
Prev Close
30.7
Open Price
30.8
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
7759
Today's High / Low
32.5 / 30.7
52 WK High / Low
45.0 / 26.1
Market Price of Concord Drugs Ltd
1M
1Y
3Y
5Y
Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2022 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 1.82 |
| YoY Gr. | - |
| Net Profit (Cr.) | 2 |
| BVPS | 32.44 |
Key Financial Parameters
| Parameter | 2022 |
|---|---|
| Return on Capital Emp. % | 8.36 |
| Op. Profit Mgn % | 9.65 |
| Net Profit Mgn % | 2.7 |
| Debt to Equity % | 0.58 |
Latest Shareholding
Promoters Holdings Over Time
About Concord Drugs Ltd
- Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
- The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
- State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.
Popular Search
FAQs for Concord Drugs Ltd Share Price History
What are the key events that typically impact Concord Drugs Ltd's share price history?
Key events that impact Concord Drugs Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Concord Drugs Ltd's share price history?
Stock splits reduce the nominal price of Concord Drugs Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Concord Drugs Ltd?
Dividends can influence Concord Drugs Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Concord Drugs Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Concord Drugs Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Concord Drugs Ltd’s share price history?
To understand Concord Drugs Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
